MyAverix Finance
F · Healthcare
Takara Bio Inc (TF2)
Biotechnology
Takara Bio Inc (TF2) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-31, reported market cap is $787.36M, P/E ratio is 18.00, net margin is -16.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TF2
Takara Bio Inc (TF2) — FAQ
What is Takara Bio Inc's market cap?
Takara Bio Inc (TF2) has a reported market cap of $787.36M (data as of 2026-03-31).
What is TF2's P/E ratio?
The price-to-earnings (P/E) ratio for Takara Bio Inc (TF2) is 18.00 (data as of 2026-03-31).
Does Takara Bio Inc pay a dividend?
Dividend yield is not available in the current snapshot for Takara Bio Inc (TF2). Check the MyAverix Finance app for the latest dividend data.
What sector is Takara Bio Inc in?
Takara Bio Inc (TF2) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TF2 listed on?
TF2 is listed on F.
What is Takara Bio Inc's net margin?
Takara Bio Inc (TF2) reports a net margin of -16.3% (data as of 2026-03-31).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.